Overview
Title
To provide a moratorium on all Federal research grants provided to any institution of higher education or other research institute that is conducting dangerous gain-of-function research.
ELI5 AI
S. 738 is a proposal to stop giving money to colleges and labs for research that makes viruses stronger or more dangerous, to keep people and animals safe.
Summary AI
S. 738 is a bill that seeks to temporarily halt all federal research grants to universities and research institutions that are engaged in dangerous gain-of-function research. Gain-of-function research involves genetically modifying organisms to enhance their biological functions, which might increase their infectivity, transmissibility, or pathogenicity. The bill defines organisms to include viruses like influenza and coronaviruses, as well as agents on government-controlled lists. This proposed moratorium aims to prevent potential risks to national security, public safety, and the health of humans and animals.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
The recently introduced bill, S. 738, titled the “Dangerous Viral Gain of Function Research Moratorium Act,” aims to impose a moratorium on all federal research grants awarded to any institution of higher education or research institutes conducting what is termed as "dangerous gain-of-function research." Introduced in the Senate by Mr. Marshall and Mrs. Blackburn, the legislation seeks to halt funding for research activities that genetically alter organisms, such as viruses, to increase their capabilities in ways that might pose a threat to public health and safety.
General Summary
The bill defines gain-of-function research as studies involving genetic modifications that enhance the biological functions of an organism—changing its infectivity, transmissibility, or pathogenicity. This includes alterations that could pose a threat to national security or public health. The organisms in question primarily include various viruses and potentially harmful agents and toxins listed by relevant federal departments. The bill's main action is to cut federal funding for any institution involved in such research.
Summary of Significant Issues
The bill has several critical issues that warrant close examination:
Broad Definitions: The definition of gain-of-function research is quite broad, potentially impacting a variety of legitimate scientific research activities. Such an encompassing definition could inadvertently stifle scientific progress by deterring researchers from pursuing lines of inquiry that might provide critical public health breakthroughs.
Vagueness and Subjectivity: The use of terms like "may be reasonably anticipated" can lead to varied interpretations, resulting in inconsistent application and enforcement. Researchers and institutions may struggle to understand whether their work falls under the prohibited category, leading to uncertainty.
Ambiguity Around Terms: The term "synthetic construct" in defining organisms is not clearly explained. This ambiguity could lead to disagreements and legal challenges over what precisely falls under the scope of the moratorium.
Lack of Definitions: The absence of defined terms like "Dangerous Viral Gain of Function Research" may obstruct a full understanding of the bill’s intent and scope, leaving stakeholders without clear guidance on compliance.
Broad Impact on the Public
The bill's passage could have significant implications for the public at large. If legitimate gain-of-function research is halted, the understanding of various pathogens and their control could suffer. This, in turn, could impact public health preparedness and the ability to respond effectively to pandemics, given that such research has historically been pivotal in developing vaccines and treatments for infectious diseases. Conversely, proponents might argue that the moratorium enhances public safety by reducing the risk of accidental leaks of potentially dangerous pathogens.
Impact on Specific Stakeholders
Research Institutions and Scientists: These entities could face considerable challenges, as funding is a critical component of sustained research. The bill might push institutions to cease certain types of research or severely restrict ongoing projects, which could delay scientific discoveries and technological advances.
Regulatory Bodies: These organizations might encounter increased pressure to develop clear guidelines and enforcement strategies, which could require additional resources and lead to bureaucratic delays.
The biotech and pharmaceutical sectors: While the moratorium could protect against possible risks associated with gain-of-function research, it might also slow down the innovation pipeline for new therapies and vaccines, affecting these industries' ability to respond to emerging health threats.
In summary, while the bill's intent to safeguard public health is undeniably crucial, its broad definitions and lack of clarity could inadvertently hinder scientific progress, impacting researchers, institutions, and the broader community engaged in essential health-related research. Careful consideration and potential revisions might be necessary to balance safety concerns with the need for scientific and medical advancement.
Issues
The definition of 'gain-of-function research' in Section 2 is broad and might encompass a wide range of research activities, potentially leading to an overly restrictive prohibition that could negatively impact legitimate scientific research. This could stifle innovation and impede advancements in the medical and scientific communities, affecting public health and safety.
The term 'may be reasonably anticipated' in the definition of gain-of-function research in Section 2 is vague and subjective, leading to a risk of inconsistent interpretation and application. This could result in arbitrary enforcement and legal challenges, as institutions may not have clear guidelines to determine what qualifies as prohibited research.
The term 'synthetic construct' in the definition of 'organism' in Section 2 is not clearly defined, which might result in confusion regarding the specific entities included in the prohibition. This ambiguity could lead to legal disputes and challenges concerning the scope of the moratorium and compliance requirements.
Section 1 lacks a definition for the term 'Dangerous Viral Gain of Function Research,' which may lead to ambiguity regarding the specific focus and intent of the moratorium. Without a clear definition, stakeholders cannot comprehensively understand the scope or objectives of the legislative action.
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The section introduces the short title of the Act, which is called the “Dangerous Viral Gain of Function Research Moratorium Act.”
2. Prohibition on Federal research grants for institutions and research institutes conducting dangerous gain-of-function research Read Opens in new tab
Summary AI
The bill section prohibits the use of federal research funds for institutions or research institutes that conduct "gain-of-function research," which involves altering organisms like viruses to increase their capabilities such as infectivity or transmissibility, posing a potential threat to public safety and security.